Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Atherosclerosis

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2012.04.021PMID 22632920PMCID PMC3389284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lp‐PLA2– a novel risk factor for high‐risk coronary and carotid artery disease

  2011cited by this paper
• Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

  2011cited by this paper
• ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.

  2011cited by this paper
• Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review

  2010cited by this paper
• Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.

  2010cited by this paper
• Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.

  2010cited by this paper
• Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.

  2008cited by this paper
• Impact of apoE genotype on oxidative stress, inflammation and disease risk.

  2008cited by this paper
• Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper.

  2007cited by this paper
• Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A2

  2007cited by this paper
• Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study.

  2006cited by this paper
• Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol Published, JLR Papers in Press, August 3, 2006.

  2006cited by this paper
• Apolipoprotein-mediated pathways of lipid antigen presentation

  2005cited by this paper
• Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A 2 , High-Sensitivity C-Reactive Protein , and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities ( ARIC ) Study

  2004cited by this paper
• MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response*

  2003cited by this paper
• Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.

  2002cited by this paper
• Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines.

  2001cited by this paper
• The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study.

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000influential reference
• Atherosclerosis is an inflammatory disease

  1999cited by this paper
• Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults.

  1998cited by this paper
• Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

  1997cited by this paper
• Apolipoprotein E. Structure, Function, and Possible Roles in Alzheimer's Disease a

  1996cited by this paper
• Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations.

  1993cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.

  1990cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper

• Lipidome and Proteome of Astrocyte and Microglia ApoE Lipoprotein Reveal Differences Based on Cell Type and ApoE Isoform.

  2026cites this paper
• The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease.

  2025cites this paper
• Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report

  2024cites this paper
• Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case–control study

  2023cites this paper
• APOE Genotypes Modulate Inflammation Independently of Their Effect on Lipid Metabolism

  2022cites this paper
• APOE ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer’s disease

  2021cites this paper
• APOE e 4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer’s disease

  2021cites this paper
• APOE gene ɛ4 allele (388C‐526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population

  2021cites this paper
• Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Hakka postmenopausal women in southern China

  2020cites this paper
• The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population

  2020cites this paper
• Methylation of Phospholipase A2 Group VII Gene Is Associated with Brain Arteriovenous Malformations in Han Chinese Populations

  2020cites this paper
• Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease

  2018cites this paper
• Chapter 4 Vascular Inflammation and Genetic Predisposition as Risk Factors for Cardiovascular Diseases

  2018cites this paper
• Vascular Inflammation and Genetic Predisposition as Risk Factors for Cardiovascular Diseases

  2018cites this paper
• Molecular Aspects of Ischemic Injury

  2018cites this paper
• Comparison of exercise treadmill test, flow mediated dilatation, and inflammation in individuals with low risk of adverse cardiovascular events

  2017cites this paper
• Isolation of Proteins which Interact with Phospholipase A2 (PLA) from Human Serum after Myocardial Infarction

  2017cites this paper
• Integrated Structural And Functional Biomarkers For Neurodegeneration

  2017cites this paper
• Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer’s Disease Development in Mexico City Young Females

  2017cites this paper
• Neuroimaging White matter hyperintensities are more highly associated with preclinical Alzheimer’s disease than imaging and cognitive markers of neurodegeneration

  2016cites this paper
• iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis

  2016cites this paper
• White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration

  2016cites this paper
• Clinical Study on Apolipoprotein E Distribution, Metabolism and Glycation

  2015cites this paper
• Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.

  2015cites this paper
• Significant interaction of APOE rs4420638 polymorphism with HDL-C and APOA-I levels in coronary heart disease in Han Chinese men.

  2015cites this paper
• Lipoprotein apheresis: present and future uses

  2015cites this paper
• Therapeutic Potential of Ginsenosides in Management of Atherosclerosis

  2015cites this paper
• Apolipoprotein E Gene Polymorphism and Risk for Coronary Heart Disease in the Chinese Population: A Meta-Analysis of 61 Studies Including 6634 Cases and 6393 Controls

  2014cites this paper
• The clinical and genetic characteristics of long-lived people from the Moscow region

  2014cites this paper
• Pathophysiological Aspects of Lipoprotein-Associated Phospholipase A 2 : A Brief Overview

  2014cites this paper
• Apolipoprotein E genotype, TNF-α 308G/A and risk for cardiac surgery associated-acute kidney injury in Caucasians

  2014cites this paper
• Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content

  2014cites this paper
• An overview of the genomics of metabolic syndrome.

  2013cites this paper
• Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review

  2013cites this paper
• World Journal of Cardiology

  year unknowncites this paper